Article by Richard Cowan is a former NORML National Director and author of What Are The Regulatory Challenges Faced By CBD Medicines?
Ramesh Ponnuru writes for Bloomberg, and he is he is also a senior editor for National Review magazine.
He also writes for The American Enterprise Institute www.AEI.org , the “conservative” think tank.
Read full here: